Feature | September 04, 2014

Henry Ford Hospital Replaces Heart Valve Outside the Heart

heart valve, heart surgery

A doctor implants a heart valve in Seattle.

September 4, 2014 – For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just outside the heart. 

Due to prior medical procedures, the metro Detroit woman was not a candidate for traditional open-heart surgery to replace her failing tricuspid valve. One major U.S. medical center turned her down for treatment. Doctors at another said her only option was a heart transplant. Henry Ford is the first hospital in the U.S. to perform the unique, transcatheter tricuspid valve replacement, which was pioneered in Germany. The woman’s tricuspid valve, one of four valves that regulates blood flow in the heart, was replaced during the 2-hour procedure July 31. The woman stayed five days in Henry Ford Hospital and was released to her home. 

“There are a lot of people who have damage of the tricuspid valve, and the surgery is risky, so doctors just try to give them medical therapy,” says William O’Neill, M.D., medical director of Henry Ford’s Center for Structural Heart Disease and lead physician for the procedure. “They get a lot of swelling and severe liver congestion. They’re in and out of the hospital, and it really causes a lot of morbitity. So there’s a huge, unmet clinical need. Individuals with this type of valve problem now have another option.”
 
Approximately 5 million people in the U.S. are diagnosed with heart valve disease annually. With an aging population that is often too frail for open-heart surgery, more than 20,000 Americans die of the disease each year, according to the American Heart Association. More than 9,100 heart patients undergo tricuspid valve surgery in the United States annually, according to the Society of Thoracic Surgeons. Replacing a tricuspid valve is one of the more difficult heart surgeries due to the valve’s location, typically requiring open heart surgery, O’Neill explains. The tricuspid valve is in the middle of the heart, in between the right ventricle and the right atrium. 
 
In the unique procedure at Henry Ford Hospital, O’Neill threaded a catheter through in a vein in the patient’s groin to her upper abdomen. There, he inserted the TAVR valve at the junction of the right atrium and the inferior vena cava (IVC), the main vein that brings deoxygenated blood back into the heart. 
 
The Henry Ford team first braced the inside of the IVC with a metal, expandable stent. He then used the catheter to insert and expand a TAVR valve to fit snugly inside. The team used 3-D modeling to create a working replica of the patient’s heart, which helped them properly plan the procedure and choose an appropriately sized valve in advance. 
 
Once deployed, the new valve stopped blood from leaking and pooling in the patient’s abdomen and lower extremities. “There’s already a huge drop in the pressure in the abdomen,” O’Neill says. Doctors monitored pressure through catheters inserted in the IVC above and below the new valve. 
 
O’Neill was assisted by Adam Greenbaum, M.D., director of the Cardiac Catheterization Lab at Henry Ford Hospital, and visiting cardiologist Brian O’Neill, M.D., assistant professor of medicine at the Temple Heart and Vascular Center. 
 
For more information: http://www.henryford.com/

Related Content

First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018
W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately...
Overlay Init